(7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid

Term ID

CHEBI:140271

Synonyms

(7S,15E,17S,19Z)-7,8,17-trihydroxydocosa-9,11,13,15,19-pentaenoic acid
(7S,8,17S)-trihydroxy-(9,11,13,15E,19Z)-docosapentaenoic acid
7,8,17-trihydroxy-omega3-docosapentaenoic acid
resolvin D1n-3 DPA
RvD1n-3 DPA

Definition

A docosanoid that is (15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid carrying three hydroxy substituents at positions 7S, 8 and 17S. An intermediate of specialised proresolving mediators

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: docosanoid hydroxy polyunsaturated fatty acid

docosanoid hydroxy polyunsaturated fatty acid Show first 5 Terms
has_role: human xenobiotic metabolite specialised pro-resolving mediator

human xenobiotic metabolite specialised pro-resolving mediator Show first 5 Terms
inverse is_conjugate_base_of: (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoate

(7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoate Show first 5 Terms
is_conjugate_acid_of: (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoate

(7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoate Show first 5 Terms

Phenotype

Phenotype resulting from (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid

Phenotype where environments contain (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid

Phenotype modified by environments containing (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid

Human Disease Model